Abstract
Malignant pleural mesotheliomas is in most cases associated with elevated amounts of hyaluronan. To investigate the importance of hyaluronan for the malignant properties of mesotheliomas, we have expressed murine hyaluronan synthase 2 (HAS2) in the non-hyaluronan producing mesothelioma cell line, Mero-25. We found that upon hyaluronan overproduction the mesothelioma cells changed their epitheloid character to a fibroblastic phenotype and were surrounded by pericellular matrices, the size of which correlated to the amount of synthesized hyaluronan. HAS2-transfected cells with the ability to synthesize about 520 ng hyaluronan/5 × 104cells/24 h exhibited about a 2-fold increase in the expression of the cell surface hyaluronan receptor CD44 and their locomotion increased compared to that of mock-transfected Mero-25 cells. Furthermore, the malignant properties of mesothelioma cell clones as determined by the ability to grow in a soft agar assay correlated to their hyaluronan production. These results provide evidence for an important role of hyaluronan in the aggressive spread of mesotheliomas in adjacent non-cancerous stromal tissues. © 2001 Cancer Research Campaign http://www.bjcancer.com
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Asplund T and Heldin P (1994) Hyaluronan receptors are expressed on human malignant mesothelioma cells but not on normal mesothelial cells. Cancer Res 54: 4516–4523
Asplund T, Versnel MA, Laurent TC and Heldin P (1993) Human mesothelioma cells produce factors that stimulate the production of hyaluronan by mesothelial cells and fibroblasts. Cancer Res 53: 388–392
Auvinen PK, Parkkinen JJ, Johansson RT, Ågren UM, Tammi RH, Eskelinen MJ and Kosma VM (1997) Expression of hyaluronan in benign and malignant breast lesions. Int J Cancer 74: 477–481
Bertrand P, Girard N, Delpech B, Duval C, d'Anjou J and Dauce JP (1992) Hyaluronan (hyaluronic acid) and hyaluronectin in the extracellular matrix of human breast carcinomas: comparison between invasive and non-invasive areas. Int J Cancer 52: 1–6
Bielefeldt-Ohmann H, Jarnicki AC and Fitzpatrick DR (1996) Molecular pathobiology and immunology of malignant mesothelioma. J Pathol 178: 369–378
Brecht M, Mayer U, Schlosser E and Prehm P (1986) Increased hyaluronate synthesis is required for fibroblast detachment and mitosis. Biochem J 239: 445–450
Brinck J and Heldin P (1999) Expression of Recombinant Hyaluronan Synthase (HAS) Isoforms in CHO Cells Reduces Cell Migration and Cell Surface CD44. Exp Cell Res 252: 342–351
Clarris BJ and Fraser JRE (1968) On the pericellular zone of some mammalian cells in vitro. Exp Cell Res 49: 181–193
Dahl IMS, Solheim ØP, Erikstein B and Müller E (1989) A longitudinal study of the hyaluronan level in the serum of patients with malignant mesothelioma under treatment. Hyaluronan as an indicator of progressive disease. Cancer 64: 68–73
Delpech B, Girard N, Olivier A, Maingonnat C, van Driessche G, van Beeumen J, Bertrand P, Duval C, Delpech A and Bourguignon J (1997) The origin of hyaluronectin in human tumors. Int J Cancer 72: 942–948
Forrester JV and Wilkinson PC (1981) Inhibition of leukocyte locomotion by hyaluronic acid. J Cell Sci 48: 315–331
Freedman VH and Shin S (1974) Cellular tumorigenicity in nude mice: correlation with cell growth in semi-solid medium. Cell 3: 355–359
Frizelle SP, Grim J, Zhou J, Gupta P, Curiel DT, Geradts J and Kratzke RA (1998) Re-expression of p16INK4a in mesothelioma cells results in cell cycle arrest, cell death, tumor suppression and tumor regression. Oncogene 16: 3087–3095
Heldin P and Pertoft H (1993) Synthesis and assembly of the hyaluronan-containing coats around normal human mesothelial cells. Exp Cell Res 208: 422–429
Heldin P, Suzuki M, Teder P and Pertoft H (1995) Chondroitin sulfate proteoglycan modulates the permeability of hyaluronan-containing coats around normal human mesothelial cells. J Cell Physiol 165: 54–61
Itano N and Kimata K (1996) Molecular cloning of human hyaluronan synthase. Biochem Biophys Res Commun 222: 816–820
Itano N, Sawai T, Miyaishi O and Kimata K (199a) Relationship between hyaluronan production and metastatic potential of mouse mammary carcinoma cells. Cancer Res 59: 2499–2504
Itano N, Sawai T, Yoshida M, Lenas P, Yamada Y, Imagawa M, Shinomura T, Hamaguchi M, Yoshida Y, Ohnuki Y, Miyauchi S, Spicer AP, McDonald JA and Kimata K (1999b) Three isoforms of mammalian hyaluronan synthases have distinct enzymatic properties. J Biol Chem 274: 25085–25092
Jacobson A, Brinck J, Briskin MJ, Spicer AP and Heldin P (2000) Expression of human hyaluronan synthases in response to external stimuli. Biochem J 348: 29–35
Kimata K, Honma Y, Okayama M, Oguri K, Hozumi M and Suzuki S (1983) Increased synthesis of hyaluronic acid by mouse mammary carcinoma cell variants with high metastatic potential. Cancer Res 43: 1347–1354
Klominek J, Robért K-H, Hjerpe A, Wickström B and Gahrton G (1989) Serum-dependent growth patterns of two, newly established human mesothelioma cell lines. Cancer Res 49: 6118–6122
Knudson W (1998) The role of CD44 as a cell surface hyaluronan receptor during tumor invasion of connective tissue. Front Bioscience 3: D604–D615
Kosaki R, Watanabe K and Yamaguchi Y (1999) Overproduction of hyaluronan by expression of the hyaluronan synthase Has2 enhances anchorage-independent growth and tumorigenesis. Cancer Res 59: 1141–1145
Laurent TC and Fraser JRE (1992) Hyaluronan. FASEB J 6: 2397–2404
Laurent TC, Laurent UBG and Fraser JRE (1995) Functions of hyaluronan. Ann Rheum Dis 54: 429–432
Lebel L, Smith L, Risberg B, Gerdin B and Laurent TC (1988) Effect of increased hydrostatic pressure on lymphatic elimination of hyaluronan from sheep lung. J Appl Physiol 64: 1327–1332
Li Y, Rahmanian M, Widström C, Lepperdinger G, Frost GI and Heldin P (2000) Irradiation-induced expression of hyaluronan (HA) synthase 2 and hyaluronidase 2 genes in rat lung tissue accompanies active turnover of HA and Induction of Types I and III Collagen gene expression. Am J Respir Cell Mol Biol 23: 411–418
Metcalf RA, Welsh JA, Bennett WP, Seddon MB, Lehman TA, Pelin K, Linnainmaa K, Tammilehto L, Mattson K and Gerwin BI (1992) p53 and Kirsten-ras mutations in human mesothelioma cell lines. Cancer Res 52: 2610–2615
Naot D, sionov RV and Ish-shalom D (1997) CD44: structure, function, and association with the malignant process. Adv Cancer Res
Nurse P (1990) Universal control mechanism regulating onset of M-phase. Nature 344: 503–507
Roggli VL, DS G and Pratt PC (1992) Pathology of Asbestos-Associated Diseases
Ropponen K, Tammi M, Parkkinen J, Eskelinen M, Tammi R, Lipponen P, Ågren U, Alhava E and Kosma VM (1998) Tumor cell-associated hyaluronan as an unfavorable prognostic factor in colorectal cancer. Cancer Res 58: 342–347
Scarpa S, Giuffrida A, Fazi M, Coletti A, Palumbo C, Pass HI, Procopio A and Modesti A (1999) Migration of mesothelioma cells correlates with histotype-specific synthesis of extracellular matrix. Int J Mol Med 4: 67–71
Shyjan AM, Heldin P, Butcher EC, Yoshino T and Briskin MJ (1996) Functional cloning of the cDNA for human hyaluronan synthase. J Biol Chem 271: 23395–23399
Spicer AP, Augustine ML and McDonald JA (1996) Molecular cloning and characterization of a putative mouse hyaluronan synthase. J Biol Chem 271: 23400–23406
Spicer AP, Olson JS and McDonald JA (1997) Molecular cloning and characterization of a cDNA encoding the third putative mammalian hyaluronan synthase. J Biol Chem 272: 8957–8961
Teder P, Versnel MA and Heldin P (1996) Stimulatory effects of pleural fluids from mesothelioma patients on CD44 expression, hyaluronan production and cell proliferation in primary cultures of normal mesothelial and transformed cells. Int J Cancer 67: 393–398
Tengblad A (1980) Quantitative analysis of hyaluronan in nanogram amounts. Biochem J 185: 101–105
Thomas L, Byers HR, Vink J and Stamenkovic I (1992) CD44H regulates tumor cell migration on hyaluronan-coated substrate. J Cell Biol 118: 971–977
Thylén A, Levin-Jacobsen A-M, Hjerpe A and Martensson G (1997) Immunohistochemical differences between hyaluronan- and non-hyaluronan-producing malignant mesothelioma. Eur Respir J 10: 404–408
Thylen A, Wallin J and Martensson G (1999) Hyaluronan in serum as an indicator of progressive disease in hyaluronan-producing malignant mesothelioma. Cancer 86: 2000–2005
Versnel MA, Bouts MJ, Hoogsteden HC, Van der Kwast TH, Delahaye M and Hagemeijer A (1989) Establishment of human malignant mesothelioma cell lines. Intern J Cancer 44: 256–260
Vindelöv LL, Christensen IJ and Nissen NI (1983) A detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis. Cytometry 3: 323–327
Watanabe K and Yamaguchi Y (1996) Molecular identification of a putative human hyaluronan synthase. J Biol Chem 271: 22945–22948
Yu Q, Toole BP and Stamenkovic I (1997) Induction of apoptosis of metastatic mammary carcinoma cells in vivo by disruption of tumor cell surface CD44 function. J Exp Med 186: 1985–1996
Zhang L, Underhill CB and Chen L (1995) Hyaluronan on the surface of tumor cells is correlated with metastatic behavior. Cancer Res 55: 428–433
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Li, Y., Heldin, P. Hyaluronan production increases the malignant properties of mesothelioma cells. Br J Cancer 85, 600–607 (2001). https://doi.org/10.1054/bjoc.2001.1922
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1054/bjoc.2001.1922
Keywords
This article is cited by
-
CD44 and its ligand hyaluronan as potential biomarkers in malignant pleural mesothelioma: evidence and perspectives
Respiratory Research (2017)
-
The deubiquitinating enzymes USP4 and USP17 target hyaluronan synthase 2 and differentially affect its function
Oncogenesis (2017)
-
Role of Pericellular Matrix in the Regulation of Cancer Stemness
Stem Cell Reviews and Reports (2016)
-
Caution Should be Used in Long-Term Treatment with Oral Compounds of Hyaluronic Acid in Patients with a History of Cancer
Clinical Drug Investigation (2015)
-
Increased CD44s and decreased CD44v6 RNA expression are associated with better survival in myxofibrosarcoma patients: a pilot study
European Journal of Medical Research (2014)